Rationale: Cardiac progenitor cells are important for maintenance of myocardial structure and function, but molecular mechanisms governing these progenitor cells remain obscure and require elucidation to enhance regenerative therapeutic approaches.
I dentification of multipotent stem cells in adult tissues such as the myocardium rests with stem cell markers originally developed to define cells of hematopoietic lineage. The c-kit cell surface receptor is commonly used to mark stem/ progenitor cells. c-kit has been identified on small nonmyocytes within the myocardium referred to as cardiac progenitor cells (CPCs) that mediate myocardial repair after ischemic injury. 1, 2 CPCs also express the cell surface marker stem cell antigen-1 (Sca-1) both in vitro 3 and in vivo. 4 Sca-1 is an 18-kDa glycosyl phosphatidylinositol-anchored cell surface protein member of the Ly-6 antigen family with cell signaling and adhesion properties 5 present on the surface of tissuespecific stem cells in the hematopoietic, 6 mammary gland, 7 and vascular niche 8 in the mouse. Although typically associated with tissue stem or progenitor cells, Sca-1 is also expressed on a variety of fully differentiated cell types. 9 
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Roles of Sca-1 protein in stem cell development and function primarily defined in the hematopoietic lineage initially described over 15 years ago in the mouse 10 led to use for marking and enrichment of stem cells. Functions of Sca-1 include promotion of adhesion and proliferation that are critical for optimal hematopoietic activity. 6 Furthermore, Sca-1 is a part of a family of proteins that contain a urokinase plasminogen activator reporter (UPAR) domain involved in cellular adhesion, migration by modulating integrin function, and degradation of the extracellular matrix. 6 In addition, Sca-1 has been implicated in signaling for cellular differentiation. 11 Isolated mesenchymal stem cells positive for both Sca-1 and c-kit differentiate into cardiomyocytes, endothelial cells, and smooth muscle cells on injection into the heart. 12 The number of Sca-1-positive cells increases in the left ventricle of the heart after myocardial infarction (MI) 13 and progenitor cells from bone marrow also migrate to injured myocardium after infarction and contribute to repair 14 suggesting that Sca-1ϩ cells contribute to regeneration and repair after an MI. Collectively, these characteristics make Sca-1 a critical protein for evaluating stem cells in the heart. Consequences of Sca-1 deletion on the functional properties of myocardial c-kitϩ CPCs and myocardial performance were assessed in the present study using Sca-1 reporter mice with a single allele GFP knock-in, Sca-1 GFP/ϩ , which labels Sca-1ϩ cells in peripheral blood with GFP. 15 Findings were generated using this Sca-1 knock-in (ScaKI) mouse model with both alleles of the Sca-1 protein coding sequence replaced with GFP downstream of the endogenous Sca-1 promoter, generating a mouse with a genetic deletion of ScaKI possessing the genotype of Sca-1 GFP/GFP . Prior studies reveal the ScaKI mouse exhibits serial bone marrow stem cell repopulating defects but has not been previously studied for a cardiac phenotype, 6 although an unrelated murine model of Sca-1 deletion has been postulated to possess an impaired response to pathological challenge due to defective Nkx2.5-positive nonmyocytes. 16 In comparison, our findings using the ScaKI line reveal deleterious effects of Sca-1 deletion on c-kitϩ CPCs and associated underlying signaling mechanisms.
Methods

Transgenic Animal Models
Sca-1 knock-in transgenic mice were a generous gift from Dr Timothy Graubert. 6, 15 A construct encoding GFP was inserted into the second exon of the Sca-1 gene at the start codon, functionally eliminating Sca-1 protein expression and creating a mouse in which GFP was expressed under the control of the endogenous Sca-1 promoter. These animals were then back-crossed into a C57/Bl6 background to create the ScaKI mice used in these experiments, which are homologous for the recombined genes resulting in a transgenic line which is negative for Sca-1 but positive for GFP wherever Sca-1 promoter is expressed. ScaKI transgenic mice were created using the C57/Bl6 background. Hereafter, C57/Bl6 animals will be denoted as normal nontransgenic control animals (NTG). All experimental procedures were designed in accordance with National Institutes of Health guidelines and approved by the San Diego State University and the Institutional Animal Care and Use Committees.
Surgical Methods
Echocardiography was performed under minimal (1.25%) isoflurane anesthesia with 2.5% supplemented oxygen using an Acuson Sequoia C256 instrument. Myocardial infarctions were carried out under 1.5% isoflurane anesthesia by ligating the left descending coronary artery with 8-0 suture. To confirm adequate ligation, cyanosis and akinesia of the affected left ventricle were observed. Sham operations were performed by opening and closing the chest. Postoperative palliative care was administered immediately and at 12 hours. Hemodynamic measurements were accomplished with a closed chest by inserting a pressure/volume catheter through the aortic valve into the left ventricle under chloral hydrate sedation. Data were collected and analyzed using a Scisense microtip pressure transducer attached to an A/D converter. To generate paraffinembedded cardiac samples, mice were heavily sedated with chloral hydrate, and the hearts were arrested in diastole by catheterizing the abdominal aorta and flushing the heart with a high potassium chloride/cadmium chloride solution. Ten percent neutral buffered formalin (NBF) fixative was perfused into the coronary arteries at systolic pressure while the left ventricle was filled with NBF at diastolic pressure. Retroperfused hearts were then removed from the chest cavity and placed in NBF overnight, followed by processing for paraffin embedding using a Leica TP1050 automated tissue processor.
Immunofluorescence Microscopy
Paraffin-embedded tissue sections, cut at 5 m, were prepared from mouse hearts that had been processed as described above. Immunohistochemistry protocol is as previously described 17 and is detailed in the online-only Data Supplement. Antibody information is detailed in Online Table I . Confocal images and counts were acquired using a Leica TCS SP2 confocal microscope.
Paraffin-Embedded Cell Counts
Hearts were harvested at the specific developmental time points described in the text and paraffin embedded. At least 3 nonsequential sections were cut and stained per heart. The area included within the count was measured using the Leica LCS Lite (Leica AG) software.
Cardiac Stem Cell Isolation and Culture
CPCs were isolated and cultured as previously described. 1 Briefly, 2 mice per preparation were anesthetized using ketamine-xylazine solution, and the heart was cannulated through the aortic arch and perfused at 37°C in oxygenated basic buffer (J-MEM, 0.7 g/L HEPES, 1.25 g/L taurine, 20 U/L insulin, Pen/Strep/Glutamine, Amphotericin, Gentamicin, pH 7.3) on a Radnotti apparatus. The heart was then digested for 12 minutes at 37°C in 320 units/Ml collagenase II in oxygenated basic buffer. Afterward, the heart was minced in basic buffer containing 0.5% bovine serum albumin and the cardiomyocytes were pelleted for 1 minute at 100g and discarded. Remaining cells in the supernatant were passed through a 25-m filter and pelleted. The cell pellet was resuspended and incubated with anti-c-kit (CD117) Miltenyi beads in PBSϩ0.5% bovine serum albumin, washed, and isolated on a Miltenyi magnetic column to extract c-kitϩ CPCs according to manufacturer's instructions. CPCs were cultured according to standard tissue culture protocols in CPC media (DMEM/F12, 10% embryonic stem cellgrade fetal bovine serum (FBS), PSG, insulin-transferrin-selenium, 1000 U/mL LIF, 40 ng/mL EGF, 20 ng/mL bFGF).
Flow Cytometry and Apoptosis Analysis
Cells were grown in complete media and analyzed by flow cytometry after nonenzymatic removal from the culture plates. The cells were resuspended at 100 000 cells in 100 L PBSϩ2% FBS, stained with directly conjugated antibodies, and analyzed after 2 wash steps. For apoptosis treatment and analysis, CPCs were seeded into 6-well plates in CPC media for at least 12 hours before treatment. 
Trypan Blue and Cyquant Assay
Cell cultures were counted after passage using 2% trypan blue solution by hemocytometer determination. For trypan blue assay, 15 000 cells per well were seeded at day 0 in a 6-well plate and counted on a hemocytometer at the indicated days post plating. For Cyquant analysis, 1000 cells per well were seeded in triplicate day 0 early in the morning in 100 L of full-growth media. In the evening of day 0 through day 5, the growth media was gently removed from the appropriate wells and replaced with 1ϫ HBSS containing Cyquant NF reagent diluted 1:500. Fluorescence was measured 30 minutes later on a Tecan Spectraflour Plus plate reader at an excitation/emission of 485/535 with a standard gain of 70.
Quantitative PCR
mRNA was isolated from cells using Zymo Research quick RNA miniprep according to manufacturer's instructions. Briefly, at least 100 000 cells per sample were collected in ZR RNA buffer, applied to a binding column, and centrifuged at 12 000 rpm for 1 minute. Flow-through was discarded and washed once with RNA wash buffer. The RNA was eluted in DNAse/RNase-free water and quantified by spectrophotometer. RT-PCR was accomplished using the Bio-Rad iScript cDNA synthesis kit according to manufacture's instructions. Briefly, 1 g of RNA per sample was added to 4 L of 5ϫ Master Mix, 1 L of 20ϫ reverse transcriptase, and RNase-free water up to 20 L. The RT-PCR reaction conditions were 5 minutes at 25°C, 30 minutes at 42°C, followed by 5 minutes 85°C. cDNA was diluted at least 1:60 in RNase/DNase-free water. Quantitative (qPCR) was accomplished using 20 to 30 g of cDNA, 3 mol/L forward and reverse primers, and 2ϫ Bio-Rad Sybr Green master mix at a final volume of 15 L. qPCR was performed on a Bio-Rad/MJ research Opticon instrument with amplification protocol: 10 minutes at 95°C; then 15 seconds at 95°C, 60 seconds at 60°C, then plate-read for 50 cycles followed by a melt curve analysis for product specificity. qPCR primer sequences are detailed in Online Table II . Fold difference analysis was calculated using the 2Ќ⌬⌬Ct method, using GAPDH as housekeeping gene control. 
siRNA
CPCs derived from FVB/N mice were plated in 10 mL full-growth media for 12 hours at 500 000 cells per 10 cm plate. The media was replaced with transfection media consisting of CPC growth media containing 0% FBS. siRNA for mouse Sca-1 (Ly6A) was obtained from Bioneer (110454, proprietary sequence) and resuspended at 100 mol/L in DNAse/RNAse-free water. Transfection mix containing 425 L of transfection media, 50 L of HiPerfect (Qiagen) transfection reagent, and 15 L of 20 mol/L siRNA was added to the 10-cm plate and incubated for 24 hours. The media was then changed to DMEM/F12 with 2.5% FBS and incubated for an additional 24 hours. Cells were then passaged and plated in full CPC media for the indicated assays.
SuperTopFlash Luciferase Assays
The SuperTopFlash 7ϫ TCF/Lef-luciferase reporter in a lentiviral expression plasmid was a kind gift of Dr Karl Willert at the University of California, San Diego. CPC lines were infected with an equal amount of SuperTopFlash lentivirus and passaged several times to insure stable expression. Cells were plated overnight and then treated for 24 hours with GSK3␤ inhibitor (Santa Cruz 202636) at 1 mol/L or ␤-catenin inhibitor (EMD 219330) at 7.5 mol/L. Luciferase expression level was assessed using the Promega BrightGlo luciferase assay according to manufacturer's instructions. Luminescence was quantified on a Tecan Spectroflour Plus plate reader.
Statistical Analysis
All probability values were determined using a paired, 2-tailed Student t test with at least 3 samples per group. Significance for qPCR analysis was determined by comparing ⌬Ct values of experimental versus control samples using a paired, 2-tailed Student t test with at least 3 samples per group.
Results
Depressed Cardiac Function in ScaKI Mice and Hypertrophy in Older Animals
Phenotypic characterization was performed to assess defects in myocardial structure and function by echocardiography, using sex-matched ScaKI and nontransgenic control mice at 12 to 18 weeks (males) as well as 12 to 14 months (male and female groups). Both young and old ScaKI mice exhibit significantly larger end-systolic diameter measurements relative to nontransgenic controls ( Figure 1A and 1B). In vivo hemodynamic measurements confirm poor cardiac function in ScaKI hearts as measured by change in pressure over change in time (dP/dT), where maximum pressure was significantly lower and minimum pressure was significantly higher in ScaKI hearts ( Figure 1C and 1D ). Fractional shortening (FS) and ejection fraction (EF) are both significantly lower in 1-year-old ScaKI mice, which also exhibited significantly larger hearts as measured by echocardiography of anterior wall dimension (AWD) and posterior wall dimension (PWD) ( Figure 1B ) and heart weight/body weight ratio ( Figure 1F ). Increased weight of old ScaKI hearts and size can be attributed to cardiomyocyte hypertrophy due to an increase in average cardiomyocyte cross-sectional area as well as significantly increased AWD and PWD ( Figure 1B and 1G). ScaKI mice also exhibit increased numbers of myocytes expressing atrial natriuretic peptide, a maker of hypertrophy, in both younger older animals (Online Figure I) . Significantly reduced survival is observed in ScaKI mice relative to normal control subjects when challenged with a very large infarction (Online Figure II) . Significantly fewer myocytes are labeled for BrdU in 28-to 30-week-old ScaKI mice relative to normal controls (Online Figure III) , consistent with loss of proliferative responsiveness in aged ScaKI hearts. Thus, hypertrophic remodeling in older animals may be accentuated in response to stress due in part to impaired cellular replacement.
Diminished Number of CPCs in ScaKI Mice
c-kit-positive CPCs are present in normal or infarcted myocardium from both nontransgenic controls as well as ScaKI tissue samples (Figure 2A through 2C) . However, significantly fewer total c-kitϩ CPCs are present in ScaKI myocardial sections from normal tissue (1.5Ϯ0.6/mm 2 ) compared with nontransgenic controls (2.6Ϯ0.8/mm 2 ; Figure 2B ). CPC migration to the zone of pathological damage increases in response to MI, peaking between 4 to 10 days after MI. 18 As true for normal myocardium, significantly fewer CPCs are present within the infarct region of ScaKI hearts (2.4Ϯ1.0/ mm 2 ) relative to nontransgenic controls (8.7Ϯ1.2/ mm 2 ; Figure 2C ), although infarct size is not significantly different between the groups as measured by percent of involved left ventricular free wall ( Figure 2D ). CPC proliferation, assessed using proliferating cell nuclear antigen 19 (PCNA), revealed c-kitϩ/PCNAϩ cells in the infarct and border region ( Figure  2E) , with significantly fewer c-kitϩ/PCNAϩ cells in the ScaKI infarct region compared with nontransgenic controls ( Figure 2F ). Comparable proliferation data were obtained using Ki67 as a proliferation marker for c-kitϩ cells in the infarct zone (Online Figure IV) . Dual positive c-kitϩ/ PCNAϩ CPCs trended higher in nontransgenic control myocardium but increase was not statistically significant (Online Figure V) . Vascular densities of infarct regions were not significantly different between normal nontransgenic versus ScaKI groups (Online Figure VII) . CPCs are distinct from mast cells, which are positive for both tryptase and c-kit. TryptaseϪ/c-kitϩ CPCs are embedded in the myocardium, whereas tryptaseϩ/c-kitϩ mast cells are present just outside the myocardium, below the epicardium, and are not included in this analysis (Online Figure VI) .
Consequences of Sca-1 Knockout on c-kit؉ Cells During Postnatal Development
The relationship between cardiac development, CPCs, and Sca-1-driven or Sca-1-driven GFP expression in the postnatal heart was determined in a developmental time course encompassing 2 days, 1 week, 2 weeks, and 12 weeks of age. Presence of CPCs phenotyped as c-kitϩ only as well as c-kitϩ/Sca-1ϩ were observed in normal nontransgenic control myocardial sections from 2 days up to adulthood ( Figure  3A and 3B) . Similarly, c-kitϩ only and c-kitϩ/GFPϩ CPCs were also observed in the ScaKI myocardium throughout all assessed time points ( Figure 3C and 3D) . Significantly fewer total c-kitϩ CPCs were present in ScaKI hearts at 2 weeks and 12 weeks of age relative to nontransgenic controls ( Figure 3E ), but this difference was not present at 2 days and 1 week of age. Further characterization of the collective c-kitϩ CPC population was performed by subdivision to determine the percentage of dual positive c-kitϩ/Sca-1ϩ CPCs in normal nontransgenic samples versus c-kitϩ/GFPϩ CPCs in ScaKI sections (necessitated as GFPϩ due to homozygous deletion of Sca-1 antigen in the ScaKI line). Significantly fewer c-kitϩ/GFPϩ cells were present at postnatal day 2 in the ScaKI hearts relative to c-kitϩ/Sca-1ϩ cells in the normal control, with a possibly compensatory concurrent increase of c-kitϩ only cells in ScaKI myocardium. Shortly thereafter at postnatal day 7, differences vanished between the controls and ScaKI for both c-kitϩ alone and dual positive c-kitϩ/Sca-1ϩ cell categories. However by 2 weeks of age onward, ScaKI hearts had significantly fewer dual positive CPCs compared with nontransgenic controls. Since significant differences were not evident for the number c-kitϩ only CPCs, decreases in the total c-kitϩ CPC population can be attributed to fewer dual positive c-kitϩ/GFPϩ CPCs in the ScaKI samples ( Figure 3F ) that are the counterparts to the dual positive c-kitϩ/Sca-1ϩ population in normal tissue. The number of Sca-1ϩ only or GFPϩ only cells in the heart was comparable between the groups at all time points examined ( Figure 3G ). Vascular endothelium in the heart also expresses Sca-1, but knock-in of GFP in the ScaKI line does not overtly affect the number or gross morphology of vessels and capillaries observed in histological sections (Online Figure VIII) .
Stem Cell Marker Expression, Decreased Proliferation, and Survival in Adult ScaKI CPCs
CPCs were isolated using the c-kit marker from both ScaKI and nontransgenic control mice to determine phenotypic properties in vitro. Resulting cultures exhibit activation of the Sca1 promoter as evidenced by GFP expression in ScaKI (37.2%, background corrected) or Sca-1 protein in nontransgenic controls (51.1%, background corrected) by flow cytometry ( Figure 4A ). Proliferation of ScaKI CPCs is depressed relative to normal CPCs ( Figure 4B ). ScaKI CPCs also show increased sensitivity to oxidative stress induced by H 2 O 2 exposure leading to apoptosis ( Figure 4C) . Impaired proliferative phenotypes generated by genetic deletion of Sca-1 were confirmed using siRNA to Sca-1 to knockdown Sca-1 in normal CPCs generated from wild-type FVB/N mice. The number of Sca-1ϩ CPCs in the culture was reduced from an average of approximately 55% in siScramble transfected cells to 10% in siSca-1 transfected cells from days 1 to 3 after plating ( Figure 4D ). Proliferative responses of siSca-1 cells are significantly reduced compared with siScramble cells by either trypan blue or Cyquant analyses ( Figure 4E and 4F) .
Altered ␤-Catenin Signaling in ScaKI CPCs
The mechanisms of Sca-1 signaling and specific genes affected by Sca-1 expression have yet to be described. However, phenotypic deficiencies in proliferation and survival in ScaKI CPCs (Figures 2-4) suggest an underlying molecular basis. Screening assays by qPCR analysis using cDNA derived from each cell line under optimal growth conditions assessed activation of multiple signaling cascades ( Figure 5A ). The canonical Wnt pathway exhibited the greatest number genes significantly changed between ScaKI CPCs versus nontransgenic controls. Several genes in the Wnt pathway showed significant changes: WNT1-inducible signaling pathway protein 1 (Wisp1), cadherin 1 (Cdh1), and lymphoid enhancer binding factor 1 (Lef1) were decreased, whereas Axin2 expression was significantly increased. Decreased expression of additional non-Wnt-related genes for vascular cell adhesion molecule 1 (VCAM1) and NLR family, apoptosis inhibitory protein 1 (Naip1/Birc1a), was also statistically significant. Quantitative changes in gene expression were confirmed by qPCR of 3 additional cDNA samples from nontransgenic control and ScaKI CPCs performed in duplicate ( Figure 5B ).
Wnt/␤-catenin gene expression alterations prompted further examination of pathway activation in ScaKI CPCs, revealing significantly elevated ␤-catenin-mediated transcriptional activity increased by 2-fold in ScaKI CPCs compared with NTG control CPCs ( Figure 5C ). Inhibition of ␤-catenin phosphorylation and ubiquitination by the pharmaceutical inhibitor GSK3␤ increased ␤-catenin/TCF/Lef transcriptional activity in NTG control CPCs (1.5-fold) and ScaKI CPCs (2-fold), confirming functional activity of this pathway in the cultured cells ( Figure 5C ). ␤-Catenin/TCF/Lef signaling is involved in switching from self-renewal to differentiated phenotypes in embryonic stem cells 20 and, similarly, increased ␤-catenin signaling in ScaKI CPCs is associated with significant elevation of MEF2c, cardiac ␣-Actinin (C␣-Actinin), ␣-smooth muscle actin (␣SMA), and SM22 relative to NTG control CPCs by qPCR analysis ( Figure 5D ). Participation of ␤-catenin in promoting commitment correlates with significant decreases in MEF2c and C␣-actinin were in ScaKI CPCs after 3 days of ␤-catenin inhibitor treatment ( Figure 5E ; 7.5 mol/L), calibrated to reduce SuperTopFlash luciferase activity but not impair proliferation (Online Figure IX) . Similar to induction of cardiac-specific transcripts in CPCs on lineage commitment, 21 the impaired proliferation and increased cardiogenic commitment of ScaKI CPCs are consistent with enhancement of a lineage-committed phenotype that appears linked to aberrant canonical Wnt signaling involving ␤-catenin.
Discussion
Maintenance and repair of myocardial structure and function depends on CPCs; therefore understanding the molecular biology of CPCs will be essential for expanding our repertoire of methodological approaches for enhancing cellular therapeutic approaches. Although Sca-1 is a widely accepted marker of stem cells in the hematopoetic system, downstream molecular signaling and consequences of Sca-1 dysregulation are poorly understood in the hematopoietic context and essentially unknown in the myocardial environment. Therefore, this study was undertaken to characterize Sca-1ϩ cells and Sca-1ϩ/c-kitϩ CPCs in particular with respect to development, function, maintenance and repair of the heart. Sca-1 has been previously used by other groups to mark mouse 3 and human 22 CPCs. Lack of Sca-1 in the adult mouse heart results in minor developmental contractile defects in agreement with observations from prior studies 16 as well as age-associated hypertrophy that has not been previously described (Figure 1) .
A critical role for Sca-1 expression for optimal myocardial and CPC function is now clear from findings in this study, although prior publications examining the hematologic system of the ScaKI mice failed to reveal an overt phenotype. 6 Since bone marrow of older (13 months old) ScaKI mice possess fewer c-kitϩ cells (Online Figure X) , we hypothesized that Sca-1 deletion would be consequential for the CPC population but only manifest in adult animals with exacerbation by aging or pathological challenge.
Myocardial function in ScaKI mice is characterized by reduced function in early adulthood and hypertrophy evolving with age. Enlarged myocytes are present in young adult ScaKI animals without a concomitant increase in heart weight/body weight ratio (Figure 1 ). This age-associated increase in average myocyte size within the ScaKI heart is presumably due to decreased new myocyte formation by CPCs 23 (Online Figure III) . Fewer c-kitϩ CPCs are present in ScaKI mice in normal or infarcted myocardium (Figure 2) , consistent with the premise of a functionally compromised stem cell population in the ScaKI heart.
Cardiac impairment in young adult mice prompted a developmental time course analysis of CPCs spanning postnatal life (2 days) until adulthood (12 weeks). Deficiencies in c-kitϩ CPCs of ScaKI hearts were significant at 2 weeks of age with lower c-kitϩ CPC number, due primarily to fewer c-kitϩ/GFPϩ in ScaKI hearts compared with c-kitϩ/Sca-1ϩ CPCs in NTG controls (Figure 3 ). Based on these observations, it is tempting to speculate that c-kitϩ/Sca-1ϩ and c-kitϩ/Sca-1Ϫ CPCs may act as distinct cell types, since if c-kitϩ CPCs in the heart were derived from c-kitϩ/Sca-1ϩ CPCs, then both groups of Sca-1ϩ and Sca-1Ϫ CPCs should be concomitantly reduced.
Cultured CPCs were successfully established from ScaKI myocardium despite lower numbers of CPCs exhibiting deficiencies in growth and survival (Figure 4 ) similar to prior reported findings in the noncardiac context. 24 Poor growth potential of ScaKI CPCs observed in vitro (Figure 4 ) parallels the in vivo observation of impaired CPC response to infarction ( Figure 2 ). Taken together, these results indicate that phenotypic characteristics of the ScaKI heart probably involve functional impairment of CPCs lacking Sca-1.
It is important to note that 2 other types of cells that normally express Sca-1 may affect the overall cardiac phenotype of the ScaKI mice: the vasculature and a subpopulation of circulating hematopoietic cells. A structural quantification of the baseline and post-MI vasculature did not reveal any overt differences in the ScaKI heart in either baseline (Online Figure VIII) or post-MI (Online Figure VII) . However, further studies are needed to assess if there is functional vascular phenotype in the ScaKI mouse. A detailed analysis of the post-MI inflammatory response is also necessary to rule out hematopoietic contributions to the ScaKI cardiac phenotype.
The molecular defect underpinning defective performance of Sca-1Ϫ CPCs appears to involve canonical Wnt signaling where ␤-catenin/TCF/Lef is the primary transcriptional effector for growth and survival ( Figure 5 ). TCF/Lef also has non-Wnt-associated functions 25 and, in the absence of activated ␤-catenin, functions as a transcriptional repressor. 26 Wnt signaling is associated with adult stem/progenitor cell proliferation, survival, and differentiation, 27 as well as cardiac development in embryogenesis. 28, 29 ScaKI CPCs show higher ␤-catenin signaling associated with phenotypic characteristics of lineage commitment at the mRNA level ( Figure 5) . Indeed, increased ␤-catenin signaling promotes differentiation in several other types of progenitor cells, such as when epithelial progenitor cells exit cell cycle and initially differentiate into mature hair follicles. 30 Strength of ␤-catenin signaling differentially determines differentiation of mesenchymal progenitor cells to either a chondrocyte or osteoblast fate, 31 and ␤-catenin signaling inhibits proliferation together with promotion of neuronal differentiation. 32 A crucial role for Sca-1 in lineage commitment and c-kit expression has also been reported for hematopoietic stem cells. 6 A recent publication on cardiac side population cells, which are Sca-1ϩ and are a putative CPC, has revealed that an excess of ␤-catenin signaling results in fewer cardiac side population cells after infarction, which is consistent with our findings. 33 Thus, overactive ␤-catenin signaling probably contributes, at least in part, to impairment of proliferation and up-regulation of cardiovascular lineage markers. Future studies will need to elaborate on the role of Wnt pathway signaling downstream of Sca-1 in CPCs.
